摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-3-碘-1H-吲唑 | 885521-72-2

中文名称
4-溴-3-碘-1H-吲唑
中文别名
4-溴-3-碘(1H)吲唑
英文名称
4-Bromo-3-iodo-1H-indazole
英文别名
4-bromo-3-iodo-2H-indazole
4-溴-3-碘-1H-吲唑化学式
CAS
885521-72-2
化学式
C7H4BrIN2
mdl
——
分子量
322.931
InChiKey
LPKLMHLJNYUOPU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    413.1±25.0 °C(Predicted)
  • 密度:
    2.421

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    28.7
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:4ae9c7eedc1915fb953b33acb4931508
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromo-3-iodo-1H-indazole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-3-iodo-1H-indazole
CAS number: 885521-72-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H4BrIN2
Molecular weight: 322.9

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    DERIVATIVES OF AZA ADAMANTANE AND USES THEREOF
    摘要:
    本发明涉及某些酰胺衍生物,具有抑制11-β-羟基类固醇脱氢酶1型(11β-HSD-1)的能力,因此在预防或治疗可以通过抑制该酶而预防或治疗的某些疾病方面具有用处。此外,本发明涉及这些化合物、其制备方法、含有这些化合物的药物组合物以及这些化合物在治疗某些疾病中的用途。预计本发明的化合物将在治疗非胰岛素依赖型2型糖尿病(NIDDM)、胰岛素抵抗、肥胖、空腹血糖受损、糖耐量受损、脂质紊乱如血脂异常、高血压以及其他疾病和病症的治疗中发挥作用。
    公开号:
    US20150141650A1
  • 作为产物:
    描述:
    2-溴-6-硝基甲苯乙酸酐氯化铵 、 potassium hydroxide 、 作用下, 以 四氢呋喃甲醇氯仿N,N-二甲基甲酰胺 为溶剂, 反应 59.33h, 生成 4-溴-3-碘-1H-吲唑
    参考文献:
    名称:
    [EN] DERIVATIVES OF AZA ADAMANTANE AND USES THEREOF
    [FR] DÉRIVÉS D'AZA-ADAMANTANE ET LEURS UTILISATIONS
    摘要:
    本发明涉及某些酰胺衍生物,具有抑制11-β-羟基类固醇脱氢酶1型(11β-HSD-1)的能力,因此在预防或治疗可以通过抑制该酶而预防或治疗的某些疾病方面具有用处。此外,本发明涉及这些化合物、其制备方法、含有这些化合物的药物组合物以及这些化合物在治疗某些疾病中的用途。预计本发明的化合物将在治疗非胰岛素依赖型2型糖尿病(NIDDM)、胰岛素抵抗、肥胖、空腹血糖受损、糖耐量受损、脂质紊乱如血脂异常、高血压以及其他疾病和病症的治疗中发挥作用。
    公开号:
    WO2013111150A1
点击查看最新优质反应信息

文献信息

  • [EN] DERIVATIVES OF AZA ADAMANTANE AND USES THEREOF<br/>[FR] DÉRIVÉS D'AZA-ADAMANTANE ET LEURS UTILISATIONS
    申请人:CONNEXIOS LIFE SCIENCES PVT LTD
    公开号:WO2013111150A1
    公开(公告)日:2013-08-01
    The present invention relates to certain amide derivatives that have the ability to inhibit 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
    本发明涉及某些酰胺衍生物,具有抑制11-β-羟基类固醇脱氢酶1型(11β-HSD-1)的能力,因此在预防或治疗可以通过抑制该酶而预防或治疗的某些疾病方面具有用处。此外,本发明涉及这些化合物、其制备方法、含有这些化合物的药物组合物以及这些化合物在治疗某些疾病中的用途。预计本发明的化合物将在治疗非胰岛素依赖型2型糖尿病(NIDDM)、胰岛素抵抗、肥胖、空腹血糖受损、糖耐量受损、脂质紊乱如血脂异常、高血压以及其他疾病和病症的治疗中发挥作用。
  • US9303016B2
    申请人:——
    公开号:US9303016B2
    公开(公告)日:2016-04-05
  • [EN] COMPOUNDS AND METHODS OF TREATING CANCERS<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE CANCERS
    申请人:[en]CULLGEN (SHANGHAI) , INC.
    公开号:WO2023193760A1
    公开(公告)日:2023-10-12
    This disclosure relates to GSPT1 degrader compounds and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds or salts, and methods of making and using the compounds or salts for the treatment of certain diseases. The disclosure also relates to methods for identifying such compounds.
  • DERIVATIVES OF AZA ADAMANTANE AND USES THEREOF
    申请人:CONNEXIOS LIFE SCIENCES PVT. LTD.
    公开号:US20150141650A1
    公开(公告)日:2015-05-21
    The present invention relates to certain amide derivatives that have the ability to inhibit 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
    本发明涉及某些酰胺衍生物,具有抑制11-β-羟基类固醇脱氢酶1型(11β-HSD-1)的能力,因此在预防或治疗可以通过抑制该酶而预防或治疗的某些疾病方面具有用处。此外,本发明涉及这些化合物、其制备方法、含有这些化合物的药物组合物以及这些化合物在治疗某些疾病中的用途。预计本发明的化合物将在治疗非胰岛素依赖型2型糖尿病(NIDDM)、胰岛素抵抗、肥胖、空腹血糖受损、糖耐量受损、脂质紊乱如血脂异常、高血压以及其他疾病和病症的治疗中发挥作用。
查看更多